Masimo Current Ratio 2007-2019 | MASI
Current and historical current ratio for Masimo (MASI) from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending September 30, 2019 was 6.23.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-09-30 | $0.93B | $0.15B | 6.23 |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.36 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| 2008-12-31 | $0.23B | $0.07B | 3.54 |
| 2008-09-30 | $0.22B | $0.05B | 4.06 |
| 2008-06-30 | $0.20B | $0.06B | 3.39 |
| 2008-03-31 | $0.17B | $0.06B | 3.18 |
| 2007-12-31 | $0.18B | $0.06B | 2.97 |
| 2007-09-30 | $0.18B | $0.06B | 2.77 |
| 2007-06-30 | $0.12B | $0.07B | 1.78 |
| 2007-03-31 | $0.00B | 0.00 | |
| 2006-09-30 | $0.00B | 0.00 | |
| 2006-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.394B | $0.858B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $126.569B | 26.22 |
| Intuitive Surgical (ISRG) | United States | $67.302B | 52.89 |
| Edwards Lifesciences (EW) | United States | $51.348B | 46.63 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.203B | 15.02 |
| IDEXX Laboratories (IDXX) | United States | $21.605B | 52.25 |
| DexCom (DXCM) | United States | $20.977B | 187.85 |
| Olympus (OCPNY) | Japan | $20.547B | 154.31 |
| Teleflex (TFX) | United States | $16.371B | 33.23 |
| Sysmex ADR (SSMXY) | Japan | $14.806B | 39.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.332B | 0.00 |
| Hologic (HOLX) | United States | $13.981B | 21.37 |
| STERIS (STE) | Ireland | $13.063B | 28.85 |
| Varian Medical Systems (VAR) | United States | $12.593B | 29.86 |
| ABIOMED (ABMD) | United States | $8.755B | 47.64 |
| Penumbra (PEN) | United States | $6.038B | 196.53 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Globus Medical (GMED) | United States | $5.609B | 34.61 |
| Integra LifeSciences Holdings (IART) | United States | $5.276B | 22.67 |
| Elekta AB (EKTAY) | Sweden | $4.749B | 36.56 |
| LivaNova (LIVN) | United Kingdom | $4.019B | 28.93 |
| Wright Medical Group (WMGI) | Netherlands | $3.788B | 229.62 |
| Tandem Diabetes Care (TNDM) | United States | $3.767B | 0.00 |
| Nevro (NVRO) | United States | $3.499B | 0.00 |
| Cantel Medical (CMD) | United States | $3.322B | 32.92 |
| Integer Holdings (ITGR) | United States | $2.502B | 17.13 |
| Nihon Kohden (NHNKY) | Japan | $2.419B | 24.34 |
| Glaukos (GKOS) | United States | $2.170B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.613B | 31.75 |
| Inogen (INGN) | United States | $1.596B | 50.40 |
| Veracyte (VCYT) | United States | $1.384B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.198B | 136.85 |
| OPKO Health (OPK) | United States | $1.092B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.078B | 0.00 |
| Natus Medical (NTUS) | United States | $1.077B | 25.90 |
| Mesa Laboratories (MLAB) | United States | $1.071B | 39.68 |
| Luminex (LMNX) | United States | $0.924B | 0.00 |
| CryoLife (CRY) | United States | $0.917B | 94.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.857B | 28.46 |
| Accelerate Diagnostics (AXDX) | United States | $0.811B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.786B | 0.00 |
| Intersect ENT (XENT) | United States | $0.673B | 0.00 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.597B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.571B | 20.53 |
| OrthoPediatrics (KIDS) | United States | $0.568B | 0.00 |
| Si-Bone (SIBN) | United States | $0.445B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.437B | 13.21 |
| Alphatec Holdings (ATEC) | United States | $0.423B | 0.00 |
| Sientra (SIEN) | United States | $0.422B | 0.00 |
| ViewRay (VRAY) | United States | $0.406B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.321B | 0.00 |
| Stereotaxis (STXS) | United States | $0.294B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.281B | 39.08 |
| IRadimed (IRMD) | United States | $0.256B | 35.94 |
| SeaSpine Holdings (SPNE) | United States | $0.248B | 0.00 |
| Accuray (ARAY) | United States | $0.246B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.230B | 64.20 |
| Fluidigm (FLDM) | United States | $0.179B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.151B | 40.00 |
| RTI Surgical (RTIX) | United States | $0.139B | 37.60 |
| ConforMIS (CFMS) | United States | $0.118B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.109B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.103B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.088B | 0.00 |
| Neuronetics (STIM) | United States | $0.084B | 0.00 |
| Electromed (ELMD) | United States | $0.083B | 29.61 |
| Vermillion (VRML) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.057B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.057B | 0.00 |
| TransEnterix (TRXC) | United States | $0.049B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.047B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.041B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.037B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.022B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.019B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.018B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.017B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.016B | 0.00 |
| Avinger (AVGR) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.75 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
